Cytokine Regulation of Disease Progression in Leprosy and Tuberculosis
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Immunobiology
- Vol. 191 (4-5) , 564-568
- https://doi.org/10.1016/s0171-2985(11)80463-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cytokine Gene Activation and Modified Responsiveness to Interleukin-2 in the Blood of Tuberculosis PatientsThe Journal of Infectious Diseases, 1993
- The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum LeprosumThe Journal of Infectious Diseases, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.The Journal of Experimental Medicine, 1992
- Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.The Journal of Experimental Medicine, 1991
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- Influence of delayed immune reactions on human epidermal keratinocytes.Proceedings of the National Academy of Sciences, 1986